Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome
Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore whether patients with restless legs syndrome (RLS)
differ from healthy subjects in daytime and night time autonomic function and cardiovascular
risk markers and whether 4 week treatment with pramipexole affects autonomic function and
cardiovascular risk markers in patients with RLS.
Phase:
Phase 4
Details
Lead Sponsor:
Mauro Manconi
Collaborators:
Cardiocentro Ticino University Hospital Inselspital, Berne